[HTML][HTML] Ischemic bowel disease in 2021
M Ahmed - World Journal of gastroenterology, 2021 - ncbi.nlm.nih.gov
Ischemic bowel disease (ISBODI) includes colon ischemia, acute mesenteric ischemia (AMI)
and chronic mesenteric ischemia (CMI). Epidemiologically, colon ischemia is the most …
and chronic mesenteric ischemia (CMI). Epidemiologically, colon ischemia is the most …
Acute and chronic ischemic disorders of the small bowel
VS Prakash, M Marin, PL Faries - Current gastroenterology reports, 2019 - Springer
Abstract Purpose of Review Ischemic disorders of the small bowel represent a rare but
highly morbid disease process which is often difficult to diagnose and has a complex …
highly morbid disease process which is often difficult to diagnose and has a complex …
[HTML][HTML] Management of acute mesenteric ischaemia: Results of a worldwide survey
B Hess, M Cahenzli, A Forbes, R Burgos… - Clinical Nutrition …, 2023 - Elsevier
Background Acute mesenteric ischaemia (AMI) is a condition with high mortality. This survey
assesses current attitudes and practices to manage AMI worldwide. Methods A …
assesses current attitudes and practices to manage AMI worldwide. Methods A …
[HTML][HTML] Outcomes of antegrade and retrograde open mesenteric bypass for acute mesenteric ischemia
ST Scali, D Ayo, KA Giles, S Gray, P Kubilis… - Journal of Vascular …, 2019 - Elsevier
Background Acute mesenteric ischemia (AMI) is a challenging clinical problem associated
with significant morbidity and mortality. Few contemporary reports focus specifically on …
with significant morbidity and mortality. Few contemporary reports focus specifically on …
Resveratrol Suppresses Gut‐Derived NLRP3 Inflammasome Partly through Stabilizing Mast Cells in a Rat Model
W Zhao, X Huang, X Han, D Hu, X Hu… - Mediators of …, 2018 - Wiley Online Library
Background. Inflammatory responses induced by intestinal ischemia‐reperfusion (IIR) lead
to serious systemic organ dysfunction and pose a challenge for current treatment. This study …
to serious systemic organ dysfunction and pose a challenge for current treatment. This study …
Prognostic factors in patients with acute mesenteric ischemia—novel tools for determining patient outcomes
S Sinz, MA Schneider, S Graber, H Alkadhi… - Surgical …, 2022 - Springer
Background Acute mesenteric ischemia (AMI) is a devastating disease with poor prognosis.
Due to the multitude of underlying factors, prediction of outcomes remains poor. We aimed to …
Due to the multitude of underlying factors, prediction of outcomes remains poor. We aimed to …
Acute mesenteric ischemia (AMI): absence of renal insufficiency and performance of early bowel resection may indicate improved outcomes
H Matthaei, A Klein, V Branchi, JC Kalff… - International journal of …, 2019 - Springer
Purpose Acute mesenteric ischemia (AMI) is still associated with very high morbidity and
mortality while the rareness and heterogeneity hamper the establishment of evidence-based …
mortality while the rareness and heterogeneity hamper the establishment of evidence-based …
Endovascular revascularization as primary treatment for acute embolic mesenteric ischemia: stent thrombectomy plus aspiration versus aspiration alone
Y Shi, H Su, L Chen, H Huang, Z Lu, J Gu - Journal of Vascular and …, 2022 - Elsevier
Purpose To investigate the outcomes of stent thrombectomy combined with aspiration
versus aspiration alone in acute mesenteric ischemia (AMI). Materials and Methods This …
versus aspiration alone in acute mesenteric ischemia (AMI). Materials and Methods This …
Mechanical thrombectomy using the solitaire AB device for acute embolic mesenteric ischemia
Y Shi, J Gu, L Chen, W Shi, MJ Ahmed, H Huang… - Journal of Vascular and …, 2019 - Elsevier
Purpose To review preliminary efficacy and safety outcomes of mechanical thrombectomy
using the Solitaire AB device combined with thromboaspiration for treatment of acute …
using the Solitaire AB device combined with thromboaspiration for treatment of acute …
Improved prognosis and low failure rate with anticoagulation as first-line therapy in mesenteric venous thrombosis
S Salim, M Zarrouk, J Elf, A Gottsäter, O Ekberg… - World Journal of …, 2018 - Springer
Background Monotherapy with anticoagulation has been considered as first-line therapy in
patients with mesenteric venous thrombosis (MVT). The aim of this study was to evaluate …
patients with mesenteric venous thrombosis (MVT). The aim of this study was to evaluate …